142 related articles for article (PubMed ID: 4017162)
1. Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.
Iguchi H; Tone H; Ishikura T; Takeuchi T; Umezawa H
Cancer Chemother Pharmacol; 1985; 15(2):132-40. PubMed ID: 4017162
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and disposition of (2''R)-4'-O-tetrahydropyranyladriamycin in dogs.
Iguchi H; Tone H; Kiyosaki T; Ishikura T; Takeuchi T; Umezawa H
Jpn J Antibiot; 1986 Feb; 39(2):638-52. PubMed ID: 3712763
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics and disposition of a new anticancer antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after a single administration].
Tone H; Iguchi H; Fujigaki M; Nishio M; Esumi Y; Takaichi M; Tsutsumi S; Yokoshima T
Jpn J Antibiot; 1986 Feb; 39(2):612-28. PubMed ID: 3712761
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer.
Mader RM; Zilg H; Schlappack O; Steger GG; Baur M; Greifenberg B; Heberle U; Dittrich C
Cancer Chemother Pharmacol; 1995; 37(1-2):91-6. PubMed ID: 7497603
[TBL] [Abstract][Full Text] [Related]
5. [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].
Nakajima O; Imamura Y; Matsumoto A; Koyama Y; Shomura T; Kawamura K; Murata S
Gan To Kagaku Ryoho; 1986 Feb; 13(2):261-70. PubMed ID: 3947106
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and disposition of a new antitumor antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after multiple administration].
Tone H; Iguchi H; Shomura T; Komiya I; Nishio M
Jpn J Antibiot; 1986 Feb; 39(2):629-37. PubMed ID: 3712762
[TBL] [Abstract][Full Text] [Related]
8. [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].
Ehninger G; Stocker HJ; Proksch B; Wilms K
Klin Wochenschr; 1980 Sep; 58(18):927-34. PubMed ID: 7206588
[TBL] [Abstract][Full Text] [Related]
9. A high performance liquid chromatographic method of analysis of 4'-O-tetrahydropyranyladriamycin and their metabolites in biological samples.
Matsushita Y; Iguchi H; Kiyosaki T; Tone H; Ishikura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1983 Jul; 36(7):880-6. PubMed ID: 6885639
[TBL] [Abstract][Full Text] [Related]
10. [Infiltration and tissue concentration of intravesically instilled (2"R)-4'-O-tetrahydropyranyladriamycin or adriamycin in rat bladder tumor induced by BBN].
Masuda H; Hirai M; Ohtawara Y; Tajima A; Aso Y
Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):577-82. PubMed ID: 2374330
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
Miller AA; Schmidt CG
Cancer Res; 1987 Mar; 47(5):1461-5. PubMed ID: 3815348
[TBL] [Abstract][Full Text] [Related]
12. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
[TBL] [Abstract][Full Text] [Related]
15. Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin.
Kunimoto S; Miura K; Takahashi Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1983 Mar; 36(3):312-7. PubMed ID: 6833151
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic studies on THP-ADM (tetrahydropyranyl adriamycin)].
Majima H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):865-70. PubMed ID: 3566297
[TBL] [Abstract][Full Text] [Related]
17. [Effect of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic, on the cardiac function of hamsters].
Tone H; Hirano S; Shirai M; Kumagai H; Okajima Y; Wakabayashi T
Jpn J Antibiot; 1986 Feb; 39(2):547-68. PubMed ID: 3712757
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].
Majima H; Iguchi H; Tone H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):542-8. PubMed ID: 3954376
[TBL] [Abstract][Full Text] [Related]
19. 4'-O-tetrahydropyranyladriamycin has greater antineoplastic activity than adriamycin in various human tumours in vitro.
Maehara Y; Sakaguchi Y; Kusumoto T; Kusumoto H; Sugimachi K
Anticancer Res; 1989; 9(2):387-9. PubMed ID: 2751263
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic analysis of adriamycin (doxorubicin) and related fluorescent compounds in Ehrlich tumor-bearing mouse plasma and tissues.
Shinozawa S; Fukuda T; Araki Y; Oda T
Acta Med Okayama; 1982 Apr; 36(2):125-32. PubMed ID: 7136849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
